Search

Search Results
Results 8441 - 8450 of 8553 for allergy
  • Iptam Migraine Relief
    Drug - 9 Mar 2023
    Consumer Medicine Information (CMI) about Iptam Migraine Relief intended for persons living in Australia.
  • Brevinor
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Brevinor-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Kyprolis
    Drug - 3 Mar 2023
    Consumer Medicine Information (CMI) about Kyprolis intended for persons living in Australia.
  • Demazin Original 6-hour Relief
    Drug - 27 Feb 2023
    Consumer Medicine Information (CMI) about Demazin Original 6-hour Relief intended for persons living in Australia.
  • Polivy
    Drug - 24 Feb 2023
    Consumer Medicine Information (CMI) about Polivy intended for persons living in Australia.
  • Lexapro® (Escitalopram oxalate) Consumer Medicine Information
    Drug - 17 Feb 2023
      Lexapro®
  • Solian
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • DBL Vancomycin
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DBL Vancomycin intended for persons living in Australia.
  • Belsomra
    Drug - 3 Feb 2023
    Consumer Medicine Information (CMI) about Belsomra intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback